EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Effects of a Patient Decision Aid for Nonmetastatic Prostate Cancer Established in Routine Care: The Randomized Controlled EvEnt-PCA Trial

Johannes Huber, Philipp Karschuck, Rainer Koch, Andreas Ihrig, Tanja Krones, Andreas Neisius, Sven von Ahn, Christian Klopf, Steffen Weikert, Michael Siebels, Nicolas Haseke, Christian Weißflog und 12 weitere

European Urology Focus · 2025

DOI: 10.1016/j.euf.2025.07.019 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Urology Focus, 2025. Verfasst von Johannes Huber und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Medical Centre, University of Heidelberg, Heidelberg, Germany; Department of Urology, Medical Faculty Carl Gustav Carus, TU Dr…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Decision Support Techniques, Patient Participation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Since 2016, >21 000 patients with prostate cancer (PC) used our personalized online decision aid in routine care in Germany. We analyzed the effects of this online decision aid for men with nonmetastatic PC in a randomized controlled trial. METHODS: In the randomized controlled EvEnt-PCA trial, 116 centers performed 1:1 allocation of 1115 patients with nonmetastatic PC to use an online decision aid (intervention = I) or a printed brochure (control = C). The primary outcome was treatment decision after 14 mo. The secondary endpoints were knowledge, acceptance, decisional conflict, physician-patient communication, anxiety and depression, decision regret, and quality of life. KEY FINDINGS AND LIMITATIONS: With complete data from 1000 patients, there was no difference between the two groups in terms of primary or secondary endpoints. In the intervention group, consultation time was shorter (I: 61 min vs C: 70 min, p = 0.02), and more patients provided a summary of their preparation (I: 76% vs C: 56%, p < 0.001). Life expectancy (I: 53% vs C: 47%, p = 0.03), radiotherapy (I: 90% vs C: 84%, p = 0.005), rehabilitation (I: 69% vs C: 62%, p = 0.02), and psycho-oncology (I: 21% vs C: 16%, p = 0.07) were discussed more frequently in the intervention group. Additionally, more counseling sessions with general practitioners (I: 43% vs C: 35%, p = 0.01) and radiotherapists (I: 24% vs C: 18%, p = 0.03) were held in the intervention group. CONCLUSIONS AND CLINICAL IMPLICATIONS: The use of the online decision aid was associated with structural improvements, for example, significantly shorter doctor-patient consultation time. Our findings suggest stronger guideline adherence in the counseling process and promotion of health literacy. Successful implementation of our online decision aid in routine care can provide an example for solving this key obstacle for shared decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsDecision Support TechniquesPatient ParticipationHumansMaleAgedMiddle AgedQuality of LifeGermanyPhysician-Patient RelationsDecision MakingPamphletsPatient Education as Topic

Stichwörter der Autor:innen

Decision aidHealth services researchProstate cancerRandomized controlled trialShared decision-making

Autor:innen und Institutionen

  • Department of Urology, Medical Centre, University of Heidelberg, Heidelberg, Germany; Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Department of Urology, Medical Centre, University of Heidelberg, Heidelberg, Germany; Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany. Electronic address: philipp.karschuck@med.uni…
  • Division of Psychooncology, Department of General Internal Medicine and Psychosomatic, University Hospital of Heidelberg, Heidelberg, Germany.
  • Institute of Biomedical Ethics and History of Medicine University of Zürich, University Hospital Zürich, Zürich, Switzerland.
  • Department of Urology, Brüderkrankenhaus Trier, Trier, Germany.
  • Department of Urology, Alexianer St. Hedwig-Krankenhaus, Berlin, Germany.

Zitieren

APA

Huber, J., Karschuck, P., Koch, R., Ihrig, A., Krones, T., Neisius, A., von Ahn, S., Klopf, C., Weikert, S., Siebels, M., Haseke, N., Weißflog, C., Baunacke, M., Liske, P., Tosev, G., Benusch, T., Schostak, M., Stein, J., Spiegelhalder, P., …, & EvEnt-PCA Study Group (2025). Effects of a Patient Decision Aid for Nonmetastatic Prostate Cancer Established in Routine Care: The Randomized Controlled EvEnt-PCA Trial. European Urology Focus. https://doi.org/10.1016/j.euf.2025.07.019

Vancouver

Huber J, Karschuck P, Koch R, Ihrig A, Krones T, Neisius A, et al. Effects of a Patient Decision Aid for Nonmetastatic Prostate Cancer Established in Routine Care: The Randomized Controlled EvEnt-PCA Trial. European Urology Focus. 2025. doi:10.1016/j.euf.2025.07.019

BibTeX
@article{Huber2025,
  author = {Huber, Johannes and Karschuck, Philipp and Koch, Rainer and Ihrig, Andreas and Krones, Tanja and Neisius, Andreas and von Ahn, Sven and Klopf, Christian and Weikert, Steffen and Siebels, Michael and Haseke, Nicolas and Weißflog, Christian and Baunacke, Martin and Liske, Peter and Tosev, Georgi and Benusch, Thomas and Schostak, Martin and Stein, Joachim and Spiegelhalder, Philipp and Thomas, Christian and Aksoy, Cem and Flegar, Luka and Groeben, Christer and EvEnt-PCA Study Group, EvEnt-PCA Study Group},
  title = {Effects of a Patient Decision Aid for Nonmetastatic Prostate Cancer Established in Routine Care: The Randomized Controlled EvEnt-PCA Trial},
  journal = {European Urology Focus},
  year = {2025},
  doi = {10.1016/j.euf.2025.07.019}
}
Kostenlos starten →